Zonisade patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
Aug, 2038

(14 years from now)

US11529333 AZURITY Oral pharmaceutical composition comprising zonisamide and process of preparation thereof
Aug, 2038

(14 years from now)

Zonisade is owned by Azurity.

Zonisade contains Zonisamide.

Zonisade has a total of 2 drug patents out of which 0 drug patents have expired.

Zonisade was authorised for market use on 15 July, 2022.

Zonisade is available in suspension;oral dosage forms.

Zonisade can be used as a method of treating seizures.

The generics of Zonisade are possible to be released after 18 August, 2038.

Drugs and Companies using ZONISAMIDE ingredient

Market Authorisation Date: 15 July, 2022

Treatment: A method of treating seizures


More Information on Dosage

ZONISADE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic